In the present study, we demonstrated that baricitinib could suppress the JAK/STAT pathway in podocytes, restore structural abnormalities induced by inflammatory conditions, and consequently prevent renal injuries in lupus-prone mice. Here, SOAT1 is linked to systemic lupus erythematosus.